The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
No more days to trade it I think. It is now suspended.
I read it as they are confirming that there is sufficient cash to pay the supplementary dividend so, yes, we will get the full 6.02p and effectively betting the 1.5p on a return of between nil and 6.48p. I'm intending to hold unless there is a sudden price surge as the potential reward is currently more than 4 times the potential loss.
"Aqua - occasionally yes but this is not a change of advisor but the appointment of joint advisors."
Except the RNS is headed "Change of Advisor" and they are announcing the appointment of Berenberg as NOMAD and joint broker and Jefferies as joint broker whereas previously finnCap were NOMAD and joint broker and WG Partners were joint brokers.
However, I agree a fund raising at this point seems most unlikely.
Does anybody have a working link for the judgement? I'm not sure if I'm being extra thick today but I can't find it!
"Dear Mr Impvesta
Please treat this message as confirmation that your voting instruction has been received and will be cast in advance of the meeting.
Thank you for your recent enquiry.
If you have any other questions, please let us know."
That's a no to the restructuring plan from me!!
Once again the HUR directors maximise the negativity in an RNS. You would have thought they could and should have been negotiating an agreement for ongoing hire of the Aoka Mizu so that they could have released details in this RNS. But no, they put out as much bad news as possible and make sure they haven't got an alternative deal in place or, if they have, they remain silent on it!
Not sure that Companies House would reflect any changes as quickly as that anyway so I wouldn't jump to any conclusions about whether the appointments are correct or false information.
"From CRS RNS, I think there is a typo in the RNS as later on in Appendix 3 it refers to Cruik as Craik twice"
Good spot! I hadn't read far enough, carefully enough!
Bloomberg shows David CrAik as a director. Crystal Amber's RNS referred to David CrUik. Is this the same person?
From this morning's RNS:
"Alchemie will commence roll out of its digital multifunction finishing solution, NOVARA, to the global textile market in Q3 2021. Work together so far has shown that using NOVARA for single-sided finishing of HeiQ Viroblock, for example, required 52% less chemistry, 66% water reduction and 50% less energy, whilst achieving a 99.7% reduction in antimicrobial activity after 15 washes at 400centigrade."
Hopefully that should read 40 degrees centigrade, not 400 centigrade!!!
Net cash inflow from operating activities $m 80,220. And that in the face of COVID 19 and low oil prices in that year.
You do wonder whether the NEDs who CA wanted to remove will now decide to take the honourable option and resign.
Think I've maybe got the worst buying record on this board as I need 1050p (Yes £10.50) per share to break even!!
Unfortunately I averaged down so many times at the wrong time and won't be investing any further funds into this one. I'm hoping my continuing patience will now start to pay dividends!
Trading update this morning:
https://www.investegate.co.uk/heiq-plc--heiq-/rns/trading-update/202101260700038338M/
So "revenue for FY 2020 exceeded market expectations" and "Operating profit for FY 2020 is anticipated to be in line with market expectations".
That sounds fairly promising but not overly helpful as the level of revenue isn't disclosed and I'm not sure what market expectations were for either revenue or operating profit.
I will shortly find out if buying in yesterday was good timing or not!